Balyasny Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.56M | Sell |
70,495
-42,270
| -37% | -$1.54M | ﹤0.01% | 1086 |
|
|
2025
Q1 | $4.08M | Buy |
112,765
+2,865
| +3% | +$104K | 0.01% | 925 |
|
|
2024
Q4 | $4.62M | Buy |
+109,900
| New | +$4.62M | 0.01% | 878 |
|
|
2024
Q2 | – | Sell |
-28,743
| Closed | -$1.34M | – | 2327 |
|
|
2024
Q1 | $1.34M | Sell |
28,743
-54,190
| -65% | -$2.53M | ﹤0.01% | 1181 |
|
|
2023
Q4 | $3.97M | Buy |
+82,933
| New | +$3.97M | 0.01% | 843 |
|
|
2023
Q1 | – | Sell |
-1,219
| Closed | -$56.5K | – | 2560 |
|
|
2022
Q4 | $56.5K | Buy |
+1,219
| New | +$56.5K | ﹤0.01% | 1894 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2685 |
|
|
2021
Q4 | – | Sell |
-3,553
| Closed | -$320K | – | 2250 |
|
|
2021
Q3 | $320K | Buy |
+3,553
| New | +$320K | ﹤0.01% | 1324 |
|
|
2021
Q2 | – | Sell |
-4,612
| Closed | -$525K | – | 1995 |
|
|
2021
Q1 | $525K | Sell |
4,612
-4,646
| -50% | -$529K | ﹤0.01% | 1208 |
|
|
2020
Q4 | $1.28M | Buy |
+9,258
| New | +$1.28M | 0.01% | 826 |
|
|
2019
Q4 | – | Sell |
-7,823
| Closed | -$335K | – | 1293 |
|
|
2019
Q3 | $335K | Buy |
+7,823
| New | +$335K | ﹤0.01% | 881 |
|
|
2019
Q2 | – | Sell |
-12,034
| Closed | -$835K | – | 1516 |
|
|
2019
Q1 | $835K | Sell |
12,034
-2,614
| -18% | -$181K | 0.01% | 968 |
|
|
2018
Q4 | $637K | Buy |
+14,648
| New | +$637K | ﹤0.01% | 937 |
|
|
2018
Q1 | – | Sell |
-9,400
| Closed | -$436K | – | 1978 |
|
|
2017
Q4 | $436K | Buy |
+9,400
| New | +$436K | ﹤0.01% | 1352 |
|
|
2017
Q3 | – | Sell |
-7,700
| Closed | -$478K | – | 1810 |
|
|
2017
Q2 | $478K | Buy |
7,700
+2,600
| +51% | +$161K | ﹤0.01% | 1044 |
|
|
2017
Q1 | $346K | Buy |
5,100
+1,800
| +55% | +$122K | ﹤0.01% | 1196 |
|
|
2016
Q4 | $232K | Buy |
+3,300
| New | +$232K | ﹤0.01% | 1061 |
|
|
2016
Q1 | – | Sell |
-43,750
| Closed | -$4.91M | – | 1264 |
|
|
2015
Q4 | $4.91M | Buy |
43,750
+1,534
| +4% | +$172K | 0.03% | 441 |
|
|
2015
Q3 | $4.07M | Buy |
42,216
+12,216
| +41% | +$1.18M | 0.03% | 458 |
|
|
2015
Q2 | $3.07M | Buy |
+30,000
| New | +$3.07M | 0.02% | 497 |
|